Latest Breaking News On - Tyler zeronda - Page 1 : comparemela.com

VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting

VYNE Therapeutics Announces Closing of Previously Announced Private Placement of $88.2 Million

VYNE Therapeutics Announces Private Placement of $88 Million - VYNE Therapeutics (NASDAQ:VYNE)

BRIDGEWATER, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company"), a clinical-stage biopharmaceutical company developing proprietary, innovative and differentiated

VYNE Therapeutics Announces Private Placement of $88

Transaction provides $88 million to fund VYNE’s clinical development programs for VYN201 and VYN202 through the end of 2025.

VYNE Therapeutics Inc.: VYNE Therapeutics Announces Reverse Stock Split

BRIDGEWATER, N.J., Feb. 10, 2023 (GLOBE NEWSWIRE) VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company"), a biopharmaceutical company developing proprietary, innovative, and differentiated